Aspergillus infections in the critically ill

Radek Dutkiewicz, Chadi Hage

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Invasive aspergillosis is a common and devastating complication in severely immune-suppressed individuals with hematologic malignancies and in hematopoietic stem cell transplant recipients. With the increase use of immunosuppressive therapies, better intensive care, and prolonged patient survival, we are experiencing a surge in the incidence of invasive aspergillosis in our critically ill patients without malignancy. In this article we discuss the epidemiology, risk factors, and clinical spectrum of invasive aspergillosis in critically ill patients without malignancy. Diagnostic methods and recommended treatments are also presented. The emphasis is placed on early diagnosis and use of new and sensitive diagnostic tools.

Original languageEnglish
Pages (from-to)204-209
Number of pages6
JournalProceedings of the American Thoracic Society
Volume7
Issue number3
DOIs
StatePublished - May 15 2010

Fingerprint

Aspergillosis
Aspergillus
Critical Illness
Infection
Hematologic Neoplasms
Critical Care
Immunosuppressive Agents
Hematopoietic Stem Cells
Early Diagnosis
Neoplasms
Epidemiology
Transplants
Survival
Incidence
Therapeutics

Keywords

  • Aspergillus
  • Chronic obstructive pulmonary disease
  • Corticosteroids
  • Galactomannan
  • Intensive care unit

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Aspergillus infections in the critically ill. / Dutkiewicz, Radek; Hage, Chadi.

In: Proceedings of the American Thoracic Society, Vol. 7, No. 3, 15.05.2010, p. 204-209.

Research output: Contribution to journalArticle

@article{172dc743f601442dacfdc20e60d4a4e2,
title = "Aspergillus infections in the critically ill",
abstract = "Invasive aspergillosis is a common and devastating complication in severely immune-suppressed individuals with hematologic malignancies and in hematopoietic stem cell transplant recipients. With the increase use of immunosuppressive therapies, better intensive care, and prolonged patient survival, we are experiencing a surge in the incidence of invasive aspergillosis in our critically ill patients without malignancy. In this article we discuss the epidemiology, risk factors, and clinical spectrum of invasive aspergillosis in critically ill patients without malignancy. Diagnostic methods and recommended treatments are also presented. The emphasis is placed on early diagnosis and use of new and sensitive diagnostic tools.",
keywords = "Aspergillus, Chronic obstructive pulmonary disease, Corticosteroids, Galactomannan, Intensive care unit",
author = "Radek Dutkiewicz and Chadi Hage",
year = "2010",
month = "5",
day = "15",
doi = "10.1513/pats.200906-050AL",
language = "English",
volume = "7",
pages = "204--209",
journal = "Annals of the American Thoracic Society",
issn = "2325-6621",
publisher = "American Thoracic Society",
number = "3",

}

TY - JOUR

T1 - Aspergillus infections in the critically ill

AU - Dutkiewicz, Radek

AU - Hage, Chadi

PY - 2010/5/15

Y1 - 2010/5/15

N2 - Invasive aspergillosis is a common and devastating complication in severely immune-suppressed individuals with hematologic malignancies and in hematopoietic stem cell transplant recipients. With the increase use of immunosuppressive therapies, better intensive care, and prolonged patient survival, we are experiencing a surge in the incidence of invasive aspergillosis in our critically ill patients without malignancy. In this article we discuss the epidemiology, risk factors, and clinical spectrum of invasive aspergillosis in critically ill patients without malignancy. Diagnostic methods and recommended treatments are also presented. The emphasis is placed on early diagnosis and use of new and sensitive diagnostic tools.

AB - Invasive aspergillosis is a common and devastating complication in severely immune-suppressed individuals with hematologic malignancies and in hematopoietic stem cell transplant recipients. With the increase use of immunosuppressive therapies, better intensive care, and prolonged patient survival, we are experiencing a surge in the incidence of invasive aspergillosis in our critically ill patients without malignancy. In this article we discuss the epidemiology, risk factors, and clinical spectrum of invasive aspergillosis in critically ill patients without malignancy. Diagnostic methods and recommended treatments are also presented. The emphasis is placed on early diagnosis and use of new and sensitive diagnostic tools.

KW - Aspergillus

KW - Chronic obstructive pulmonary disease

KW - Corticosteroids

KW - Galactomannan

KW - Intensive care unit

UR - http://www.scopus.com/inward/record.url?scp=77955478959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955478959&partnerID=8YFLogxK

U2 - 10.1513/pats.200906-050AL

DO - 10.1513/pats.200906-050AL

M3 - Article

C2 - 20463249

AN - SCOPUS:77955478959

VL - 7

SP - 204

EP - 209

JO - Annals of the American Thoracic Society

JF - Annals of the American Thoracic Society

SN - 2325-6621

IS - 3

ER -